Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment

NCT00466609 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Obsessive Compulsive Disorder

Interventions

DRUG: Clomipramine (fluoxetine plus clomipramine)
DRUG: Quetiapine (fluoxetine plus quetiapine)
DRUG: Placebo (fluoxetine plus placebo)

Sponsor

University of Sao Paulo

Collaborators

[object Object]
[object Object]
[object Object]